Access to capital is the #1 issue we hear from our members, so we are offering a NEW member-only service to help iBIO Members access non-dilutive funding from the government. By teaming up with G2G Consulting, which has secured over $528 million in government funding since 2007, iBIO will send out a monthly report on life sciences grants and offer monthly webinars with government funding experts to ask questions and gain insights on how to obtain funding. This Government Biosciences Grant Report or GBG Report is updated and published monthly with all life sciences opportunities spanning from NIH to BARDA to DoD to USDA to NSF to ARPA-H included.
December’s GBG report includes 131 non-dilutive government funding opportunities, notices of special interest, and other opportunities
- December 15, 2023 – Join us for G2G’s Monthly Non-Dilutive Funding: GBG Reporting Service Webinar at 9-9:30 am CST (FREE and open to all) then from 9:30-10 am CST (premium service and private consultation for iBIO members, G2G clients and GBG customers).
- Conference Alert (GBG pg. 2 – Header): G2G will be at the JP Morgan Healthcare Conference from January 8-11 in San Francisco, and participating in a special panel event on Equity in Health: Perspectives on Women’s Health Innovation on January 9. Please reach out if you’re attending the conference and would like to connect.
- Miniaturization and Automation of Tissue Chip Systems (MATChS) – (GBG pg. 3, line 3) – NIH/NCATS seek to fund technology development research efforts in instrumentation innovation and approaches for automation and miniaturization of microphysiological systems (MPS).
- Pre-Announcement: Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (GBG pg. 3, line 6)– NIH seeks to advance new cell therapy strategies into clinical testing for the treatment of solid tumors in pediatric cancer patients.
- Defense Health Agency (DHA) SBIR 24.1 – Phase I & Direct to Phase II – (GBG pg. 12, line 43) – DHA seeks proposals for various topic areas including: Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device; Development of a Junctional Tourniquet; Rapid Manufacturing of Personalized Braces and Splints for Musculoskeletal Injury; and Wireless, Wearable Personal Metabolic Sensors